![]() | ![]() |
Formats:
|
||||
Observations on the systemic effect of topical clobetasol propionate (Dermovate). This article has been cited by other articles in PMC.Abstract Topical application of clobetasol propionate in a strength of 0-05% in cream or ointment (Dermovate) suppressed the hypothalamic-pituitary-adrenal axis in both normal people and patients with diseased skin. In normal people the 9 am serum cortisol level was suppressed when between 45 and 90 g was applied weekly. Insulin stress test results in patients with diseased skin showed an abnormally small response after long-term application of similar amounts. We conclude that long-term administration should be restricted to less than 50 g a week. Full text Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (368K), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References. Selected References These references are in PubMed. This may not be the complete list of references from this article.
|
PubMed related articles
Your browsing activity is empty. Activity recording is turned off. |
|||